Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myelo Dysplastic Syndrome”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Early research (Phase 1)Study completedNCT02352558
What this trial is testing

BBI608 in Adult Patients With Advanced, Refractory Hematologic Malignancies

Who this might be right for
Hematologic Malignancy
Sumitomo Pharma America, Inc. 15
Testing effectiveness (Phase 2)Looking for participantsNCT07098936
What this trial is testing

Momelotinib in VEXAS Syndrome

Who this might be right for
VEXAS SyndomeMyelo Dysplastic Syndrome
Groupe Francophone des Myelodysplasies 57
Post-approval studies (Phase 4)Study completedNCT02805946
What this trial is testing

Pharmacokinetics of Posaconazole (Noxafil®) as Prophylaxis for Invasive Fungal Infections

Who this might be right for
Allogeneic Stem Cell TransplantAcute Graft Versus Host DiseaseAcute Myeloid Leucaemia+1 more
Radboud University Medical Center 21
Testing effectiveness (Phase 2)Study completedNCT02172768
What this trial is testing

Pharmacokinetics of Micafungin Given Twice Weekly Intravenously Compared to Micafungin Given Daily to Patients at Risk for Developing an Invasive Fungal Disease

Who this might be right for
Acute Graft Versus Host Disease Grade II-IVAllogeneic Stem Cell TransplantAcute Myeloid Leucaemia+1 more
Radboud University Medical Center 30
Not applicableNot Yet RecruitingNCT07210034
What this trial is testing

What is the Prognostic Value of HALP Score, Monocytopenia, Hypofibrinogenemia, and AST/ALT Ratio in Patients With Myelodysplastic Syndromes

Who this might be right for
Myelo Dysplastic Syndrome
Assiut University 100